Cargando…
Polymorphisms, endogenous hormone levels and familial breast cancer risk in premenopausal women
Autores principales: | Walker, K, Fletcher, O, Johnson, N, Palles, C, Folkerd, E, Hillier, SG, Moss, S, Gibson, L, Dowsett, M, Peto, J, dos santos Silva, I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875587/ http://dx.doi.org/10.1186/bcr2522 |
Ejemplares similares
-
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.
por: Thomas, H. V., et al.
Publicado: (1997) -
Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009) -
Correlation of age and hormone replacement therapy with breast density as assessed by Quantra™
por: Skippage, PL, et al.
Publicado: (2009) -
Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study
por: Schoemaker, M J, et al.
Publicado: (2014) -
Epidemiological changes in premenopausal patients with breast cancer: a two-decade retrospective study
por: Garcia-Faura, A, et al.
Publicado: (2009)